These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancer. Low YS; Blöcker C; McPherson JR; Tang SA; Cheng YY; Wong JYS; Chua C; Lim TKH; Tang CL; Chew MH; Tan P; Tan IB; Rozen SG; Cheah PY Cancer Lett; 2017 Sep; 403():13-20. PubMed ID: 28624625 [TBL] [Abstract][Full Text] [Related]
45. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy. Lee YC; Su CY; Lin YF; Lin CM; Fang CY; Lin YK; Hsiao M; Chen CL Oncotarget; 2017 Feb; 8(7):12120-12132. PubMed ID: 28076332 [TBL] [Abstract][Full Text] [Related]
46. A signature for induced pluripotent stem cell-associated genes in colorectal cancer. Liu YH; Li Y; Liu XH; Sui HM; Liu YX; Xiao ZQ; Zheng P; Chen L; Yao S; Xing C; Zhou J; Li JM Med Oncol; 2013 Mar; 30(1):426. PubMed ID: 23307247 [TBL] [Abstract][Full Text] [Related]
47. p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis. Solé L; Lobo-Jarne T; Álvarez-Villanueva D; Alonso-Marañón J; Guillén Y; Guix M; Sangrador I; Rozalén C; Vert A; Barbachano A; Lop J; Salido M; Bellosillo B; García-Romero R; Garrido M; González J; Martínez-Iniesta M; López-Arribillaga E; Salazar R; Montagut C; Torres F; Iglesias M; Celià-Terrassa T; Muñoz A; Villanueva A; Bigas A; Espinosa L Nat Commun; 2022 May; 13(1):2866. PubMed ID: 35606354 [TBL] [Abstract][Full Text] [Related]
48. TBL1XR1 predicts isolated tumor cells and micrometastasis in patients with TNM stage I/II colorectal cancer. Liu H; Liu Z; Li K; Li S; Song L; Gong Z; Shi W; Yang H; Xu Y; Ning S; Ismail S; Chen Y J Gastroenterol Hepatol; 2017 Sep; 32(9):1570-1580. PubMed ID: 28127799 [TBL] [Abstract][Full Text] [Related]
49. Relationships between the expressions of CDX1 and CDX2 mRNA and clinicopathologic features in colorectal cancers. Kim GH; Lee DH; Kim HW; Cheong JY; Seo SB; Heo J; Kang DH; Song GA; Cho M; Yang US; Park DY; Yoo MA Korean J Intern Med; 2005 Dec; 20(4):317-24. PubMed ID: 16491830 [TBL] [Abstract][Full Text] [Related]
50. Multiple microRNAs induced by Cdx1 suppress Cdx2 in human colorectal tumour cells. Tagawa T; Haraguchi T; Hiramatsu H; Kobayashi K; Sakurai K; Inada K; Iba H Biochem J; 2012 Nov; 447(3):449-55. PubMed ID: 22849325 [TBL] [Abstract][Full Text] [Related]
51. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer. Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976 [TBL] [Abstract][Full Text] [Related]
52. DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines. Suh ER; Ha CS; Rankin EB; Toyota M; Traber PG J Biol Chem; 2002 Sep; 277(39):35795-800. PubMed ID: 12124393 [TBL] [Abstract][Full Text] [Related]
53. A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome. Schell MJ; Yang M; Missiaglia E; Delorenzi M; Soneson C; Yue B; Nebozhyn MV; Loboda A; Bloom G; Yeatman TJ Clin Cancer Res; 2016 Feb; 22(3):734-45. PubMed ID: 26446941 [TBL] [Abstract][Full Text] [Related]
54. Two circPPFIA1s negatively regulate liver metastasis of colon cancer via miR-155-5p/CDX1 and HuR/RAB36. Ji H; Kim TW; Lee WJ; Jeong SD; Cho YB; Kim HH Mol Cancer; 2022 Oct; 21(1):197. PubMed ID: 36224588 [TBL] [Abstract][Full Text] [Related]
55. An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy. Yang M; Davis TB; Pflieger L; Nebozhyn MV; Loboda A; Wang H; Schell MJ; Thota R; Pledger WJ; Yeatman TJ BMC Cancer; 2022 Mar; 22(1):256. PubMed ID: 35272617 [TBL] [Abstract][Full Text] [Related]
56. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer. Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239 [TBL] [Abstract][Full Text] [Related]
57. Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells. Mizoshita T; Inada K; Tsukamoto T; Nozaki K; Joh T; Itoh M; Yamamura Y; Ushijima T; Nakamura S; Tatematsu M J Cancer Res Clin Oncol; 2004 Jan; 130(1):29-36. PubMed ID: 14615935 [TBL] [Abstract][Full Text] [Related]
58. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer. Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319 [TBL] [Abstract][Full Text] [Related]
59. Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development. Kazumori H; Ishihara S; Kinoshita Y Gut; 2009 May; 58(5):620-8. PubMed ID: 19136512 [TBL] [Abstract][Full Text] [Related]
60. CXCL10 expression and prognostic significance in stage II and III colorectal cancer. Jiang Z; Xu Y; Cai S Mol Biol Rep; 2010 Jul; 37(6):3029-36. PubMed ID: 19821051 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]